Skip to content

Optidos

by Ptw-New York Corp.

510(k) K010705

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK010705 Date11 Mar 2003ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KXK
Device Class
Class II
Regulation
21 CFR Part 892.5730
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Optidos is a Source, Brachytherapy, Radionuclide device, classified as a Class II medical device under FDA regulation 892.5730. It is designed for use in radiology procedures, specifically as a brachytherapy source for internal radiation therapy, delivering precise radioactive emissions to targeted tissue.

Supplied by Ptw-New York Corp., the Optidos is intended for single-use applications in controlled clinical settings. It is regulated under the FDA’s 510(k) clearance process (K010705) and falls under the Radiology advisory committee’s purview. The device is not described as MRI-safe or reusable, and its sterility or storage conditions are not specified in the available data.

Other devices from Ptw-New York Corp.

See all devices from Ptw-New York Corp. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Optidos used for in medical procedures?

    The Optidos is designed specifically for brachytherapy, a form of internal radiation therapy. It delivers targeted radioactive emissions directly to tissue, allowing precise treatment of localized areas during radiology procedures. This is particularly useful in oncology for treating cancers where external radiation may not be as effective or safe.

  • Is the Optidos device intended for single-use or reusable applications?

    The Optidos is supplied for single-use applications only. This design ensures patient safety and sterility, as single-use devices are not intended to be reused or reprocessed. Reuse could compromise the integrity of the radioactive source and introduce risks to both patients and clinicians.

  • What regulatory pathway does the Optidos follow, and who oversees its clearance?

    The Optidos is classified as a Class II medical device under FDA regulation 892.5730 and follows the 510(k) clearance process. It was reviewed by the FDA’s Radiology Advisory Committee (RA) and received clearance under the traditional pathway with the decision code SESE (Substantially Equivalent). The clearance number assigned is K010705.

  • Are there specific storage conditions or sterility guarantees mentioned for the Optidos?

    The available data does not specify storage conditions or sterility guarantees for the Optidos. Clinicians should follow standard radiation safety protocols for handling radioactive sources and consult manufacturer guidelines for proper storage and handling to ensure safety and efficacy.

  • What types of radiology procedures can the Optidos be used in?

    The Optidos is intended for use in brachytherapy procedures within radiology, where precise internal radiation delivery is required. This includes treatments for cancers such as prostate, cervical, or breast cancer, where localized radiation is administered directly to the tumor site. Its use is restricted to controlled clinical settings where trained professionals can manage radioactive materials safely.